Develop FDA Clinical Trials and Labeling with Payment in Mind

Develop FDA Clinical Trials and Labeling with Payment in Mind
John B. Reiss, Author
Update Magazine

John B. Reiss, a Partner in the Business and Finance Department and a member of the Health Law and Life Sciences practice groups, wrote this article for the Food and Drug Law Institute's Update magazine that explains what medical device manufacturers and developers should think about prior to developing Food and Drug Administration labeling or clinical trials.

To read the full article, please click the link below.